<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Nutr Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Nutr Sci</journal-id><journal-id journal-id-type="publisher-id">JNS</journal-id><journal-title-group><journal-title>Journal of Nutritional Science</journal-title></journal-title-group><issn pub-type="epub">2048-6790</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25191571</article-id><article-id pub-id-type="pmc">4153034</article-id><article-id pub-id-type="doi">10.1017/jns.2013.16</article-id><article-id pub-id-type="pii">S2048679013000165</article-id><article-id pub-id-type="publisher-id">00016</article-id><article-categories><subj-group subj-group-type="heading"><subject>Nutritional Endocrinology</subject></subj-group></article-categories><title-group><article-title>A single supplement of a standardised bilberry (<italic>Vaccinium
myrtillus</italic> L.) extract (36 % wet weight anthocyanins) modifies glycaemic response
in individuals with type 2 diabetes controlled by diet and lifestyle</article-title><alt-title alt-title-type="left-running">Nigel Hoggard <italic>et al.</italic></alt-title><alt-title alt-title-type="right-running">A single supplement of a standardised
bilberry</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hoggard</surname><given-names>Nigel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Cruickshank</surname><given-names>Morven</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Moar</surname><given-names>Kim-Marie</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bestwick</surname><given-names>Charles</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Holst</surname><given-names>Jens J.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Russell</surname><given-names>Wendy</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Horgan</surname><given-names>Graham</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib></contrib-group><aff id="aff1"><label>1</label><institution>Rowett Institute of Nutrition and Health,
University of Aberdeen</institution>, <addr-line>Aberdeen Centre for Energy Regulation and
Obesity (ACERO), Bucksburn, Aberdeen AB21 9SB</addr-line>, <country>UK</country></aff><aff id="aff2"><label>2</label><addr-line>The NNF Centre for Basic Metabolic Research,
Department of Biomedical Sciences, The Panum Institute</addr-line>,
<institution>University of Copenhagen</institution>, <addr-line>Copenhagen</addr-line>,
<country>Denmark</country></aff><aff id="aff3"><label>3</label><institution>Biomathematics and Statistics
Scotland</institution>, <addr-line>Bucksburn, Aberdeen AB21 9SB</addr-line>,
<country>UK</country></aff><author-notes><corresp id="cor1"><label>*</label><addr-line><bold>Corresponding author:</bold> Dr Nigel
Hoggard</addr-line>, fax <fax>+ 44 1224 438629</fax>, email <email>N.Hoggard@abdn.ac.uk</email></corresp></author-notes><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>24</day><month>7</month><year>2013</year></pub-date><volume>2</volume><elocation-id>e22</elocation-id><history><date date-type="received"><day>20</day><month>2</month><year>2013</year></date><date date-type="rev-recd"><day>25</day><month>4</month><year>2013</year></date><date date-type="accepted"><day>04</day><month>5</month><year>2013</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2013</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access"><license-p><!--CREATIVE COMMONS-->The online version of this article is published within an Open Access
environment subject to the conditions of the Creative Commons
Attribution-NonCommercial-ShareAlike licence
&#x0003c;<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-sa/2.5/">http://creativecommons.org/licenses/by-nc-sa/2.5/</ext-link>&#x0003e;. The written
permission of Cambridge University Press must be obtained for commercial
re-use.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="S2048679013000165a.pdf"/><abstract abstract-type="normal"><p>Dietary strategies for alleviating health complications associated with type 2 diabetes
(T2D) are being pursued as alternatives to pharmaceutical interventions. Berries such as
bilberries (<italic>Vaccinium myrtillus</italic> L.) that are rich in polyphenols may
influence carbohydrate digestion and absorption and thus postprandial glycaemia. In
addition, berries have been reported to alter incretins as well as to have antioxidant and
anti-inflammatory properties that may also affect postprandial glycaemia. The present
study investigated the acute effect of a standardised bilberry extract on glucose
metabolism in T2D. Male volunteers with T2D (<italic>n</italic> 8; BMI 30 (<sc>sd</sc> 4)
kg/m<sup>2</sup>) controlling their diabetes by diet and lifestyle alone were given a
single oral capsule of either 0&#x000b7;47&#x000a0;g standardised bilberry extract (36 % (w/w)
anthocyanins) which equates to about 50&#x000a0;g of fresh bilberries or placebo followed by a
polysaccharide drink (equivalent to 75&#x000a0;g glucose) in a double-blinded cross-over
intervention with a 2-week washout period. The ingestion of the bilberry extract resulted
in a significant decrease in the incremental AUC for both glucose
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;003) and insulin (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;03) compared with the
placebo. There was no change in the gut (glucagon-like peptide-1, gastric inhibitory
polypeptide), pancreatic (glucagon, amylin) or anti-inflammatory (monocyte chemotactic
protein-1) peptides. In addition there was no change in the antioxidant (Trolox equivalent
antioxidant capacity, ferric-reducing ability of plasma) responses measured between the
volunteers receiving the bilberry extract and the placebo. In conclusion the present study
demonstrates for the first time that the ingestion of a concentrated bilberry extract
reduces postprandial glycaemia and insulin in volunteers with T2D. The most likely
mechanism for the lower glycaemic response involves reduced rates of carbohydrate
digestion and/or absorption.</p></abstract><kwd-group><title>Key words</title><kwd>Bilberries</kwd><kwd>Anthocyanins</kwd><kwd>Type 2 diabetes</kwd><kwd>Glycaemic response</kwd></kwd-group><kwd-group kwd-group-type="abbreviations"><title>Abbreviations</title><kwd>AUCi, incremental AUC</kwd><kwd>FRAP, ferric-reducing ability of plasma</kwd><kwd>GIP, gastric inhibitory polypeptide</kwd><kwd>GLP-1, glucagon-like peptide-1</kwd><kwd>MCP-1, monocyte chemotactic protein-1</kwd><kwd>OGTT, oral glucose tolerance test</kwd><kwd>T2D, type 2 diabetes</kwd><kwd>TEAC, Trolox equivalent antioxidant capacity</kwd></kwd-group><counts><fig-count count="4"/><table-count count="1"/><ref-count count="46"/><page-count count="9"/></counts></article-meta></front><body><p>Dietary strategies for alleviating health complications, such as premature vascular disease,
associated with type 2 diabetes (T2D) and obesity are actively being pursued as alternatives
to pharmaceutical interventions<sup>(</sup><xref rid="ref1" ref-type="bibr">
<sup>1</sup>
</xref><sup>)</sup>. The genus <italic>Vaccinium</italic> (for example, blueberry, bilberry,
cranberry) has been used traditionally as a source of folk remedies for established diabetic
symptoms.</p><p>Berries from this genus are rich in anthocyanins, polyphenols recognised for their ability to
provide and activate cellular antioxidant protection and inhibit inflammatory gene
expression<sup>(</sup><xref rid="ref2" ref-type="bibr">
<sup>2</sup>
</xref><sup>&#x02013;</sup><xref rid="ref4" ref-type="bibr">
<sup>4</sup>
</xref><sup>)</sup>, activities that may contribute to the efficacy of the
<italic>Vaccinium</italic> genus as ameliorators for T2D. Consumption of a freeze-dried
blueberry beverage for an 8-week period, for example, decreased plasma concentrations of the
cardiovascular risk factors oxidised LDL, malondialdehyde and hydroxynonenal. In another
trial, bioactives from blueberries improved insulin sensitivity in obese insulin-resistant men
and women<sup>(</sup><xref rid="ref5" ref-type="bibr">
<sup>5</sup>
</xref><sup>,</sup><xref rid="ref6" ref-type="bibr">
<sup>6</sup>
</xref><sup>)</sup>. In both these studies the investigators reported no change in
inflammatory markers following supplementation although bilberry juice was shown to modulate
plasma markers of inflammation C-reactive protein and IL-6 in subjects with increased risk of
CVD<sup>(</sup><xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref><sup>)</sup>. These beneficial responses from human studies are supported by data that
demonstrate long-term beneficial effects of anthocyanins from mouse models of obesity and
diabetes<sup>(</sup><xref rid="ref8" ref-type="bibr">
<sup>8</sup>
</xref><sup>&#x02013;</sup><xref rid="ref12" ref-type="bibr">
<sup>12</sup>
</xref><sup>)</sup>.</p><p>There are also a number of studies <italic>in vitro</italic> and <italic>in vivo</italic>
that suggest that polyphenols influence carbohydrate digestion and absorption, resulting in
improved postprandial glycaemia in the short term. Polyphenols inhibit intestinal
&#x003b1;-glucosidase activity<sup>(</sup><xref rid="ref13" ref-type="bibr">
<sup>13</sup>
</xref><sup>&#x02013;</sup><xref rid="ref17" ref-type="bibr">
<sup>17</sup>
</xref><sup>)</sup> and glucose transport<sup>(</sup><xref rid="ref13" ref-type="bibr">
<sup>13</sup>
</xref><sup>,</sup><xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref><sup>,</sup><xref rid="ref18" ref-type="bibr">
<sup>18</sup>
</xref><sup>&#x02013;</sup><xref rid="ref21" ref-type="bibr">
<sup>21</sup>
</xref><sup>)</sup>
<italic>in vitro</italic>. In association with this, polyphenols administered to rodents
suppress the elevation of blood glucose concentration after oral administration of mono- and
di-saccharides<sup>(</sup><xref rid="ref13" ref-type="bibr">
<sup>13</sup>
</xref><sup>&#x02013;</sup><xref rid="ref17" ref-type="bibr">
<sup>17</sup>
</xref><sup>,</sup><xref rid="ref19" ref-type="bibr">
<sup>19</sup>
</xref><sup>,</sup><xref rid="ref22" ref-type="bibr">
<sup>22</sup>
</xref><sup>)</sup>. In human subjects, several studies have examined the effect of
polyphenols on the postprandial glycaemic response<sup>(</sup><xref rid="ref23" ref-type="bibr">
<sup>23</sup>
</xref><sup>)</sup>. In one study, a test meal of mixed berry pur&#x000e9;e with sucrose showed a
lower plasma glucose concentration after 15&#x02013;30&#x000a0;min compared with a control matched for
sugars<sup>(</sup><xref rid="ref24" ref-type="bibr">
<sup>24</sup>
</xref><sup>)</sup>.</p><p>Overall, evidence suggests that consuming edible berries, particularly from the genus
<italic>Vaccinium</italic>, that have high concentrations of anthocyanins could provide a
supplementary intervention to improve glycaemia in subjects with T2D or impaired glucose
tolerance. The object of the present study was to investigate whether a single supplementation
with a standardised (36 % (w/w) anthocyanins) concentrated bilberry extract could alter
glucose metabolism in overweight/obese volunteers with impaired glucose intolerance or T2D
compared with a control capsule matched for sugars and to explore the possible mechanisms of
action.</p><sec sec-type="methods" id="sec1"><title>Methods</title><sec id="sec1-1" sec-type="subjects"><title>Subjects</title><p>Male volunteer subjects (<italic>n</italic> 8; BMI 30 (<sc>sd</sc> 4) kg/m<sup>2</sup>;
aged 62 (<sc>sd</sc> 5) years) with T2D controlled by diet and lifestyle alone or with
impaired glucose tolerance (<xref ref-type="table" rid="tab01">Table 1</xref>) were
recruited from the Aberdeen area of the UK. Subjects were only included if they were not
on any special religious or prescribed diet and had a stable weight. Medical exclusion
criteria included chronic illnesses, such as thromboembolic or coagulation problems,
thyroid disease, renal or hepatic disease, severe gastrointestinal disorders, pulmonary
disease (for example, chronic bronchitis, chronic obstructive pulmonary disease), alcohol
or any other substance abuse, eating disorders or psychiatric disorders. Volunteers were
also excluded if they were taking oral steroids, tricyclic antidepressants, neuroleptics,
anticoagulants, digoxin and anti-arrhythmics, or chronically using anti-inflammatories
(for example, high doses of aspirin, ibuprofen) or nutrient supplements. These criteria
were checked with each participant's primary care physician. All subjects provided
informed written consent before inclusion in the study, which was approved by the North of
Scotland Research Ethics Committee (NOSREC). The study was registered at
clinicaltrials.gov no. NCT01245270 and was conducted according to the guidelines laid down
in the Declaration of Helsinki. On both visits, all anthropometric measurements were made
following an overnight fast. <table-wrap id="tab01" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Baseline characteristics of the lean and overweight diabetic study volunteers
(<italic>n</italic> 8)</p><p>(Mean values and standard deviations)</p></caption><alternatives><graphic xlink:href="S2048679013000165_tab1"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><thead><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">62&#x000b7;13</td><td rowspan="1" colspan="1">4&#x000b7;55</td></tr><tr><td rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">30&#x000b7;32</td><td rowspan="1" colspan="1">4&#x000b7;38</td></tr><tr><td rowspan="1" colspan="1">Height (cm)</td><td rowspan="1" colspan="1">174&#x000b7;35</td><td rowspan="1" colspan="1">7&#x000b7;37</td></tr><tr><td rowspan="1" colspan="1">Body weight (kg)</td><td rowspan="1" colspan="1">92&#x000b7;33</td><td rowspan="1" colspan="1">15&#x000b7;05</td></tr><tr><td rowspan="1" colspan="1">Body weight:height ratio</td><td rowspan="1" colspan="1">0&#x000b7;53</td><td rowspan="1" colspan="1">0&#x000b7;08</td></tr><tr><td rowspan="1" colspan="1">Waist circumference (cm)</td><td rowspan="1" colspan="1">105&#x000b7;9</td><td rowspan="1" colspan="1">11&#x000b7;44</td></tr><tr><td rowspan="1" colspan="1">Hip circumference (cm)</td><td rowspan="1" colspan="1">105&#x000b7;1</td><td rowspan="1" colspan="1">5&#x000b7;83</td></tr><tr><td rowspan="1" colspan="1">Waist:hip circumference ratio</td><td rowspan="1" colspan="1">1&#x000b7;01</td><td rowspan="1" colspan="1">0&#x000b7;06</td></tr><tr><td rowspan="1" colspan="1">Blood pressure (mmHg)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Systolic</td><td rowspan="1" colspan="1">142&#x000b7;5</td><td rowspan="1" colspan="1">15&#x000b7;70</td></tr><tr><td rowspan="1" colspan="1">Diastolic</td><td rowspan="1" colspan="1">81&#x000b7;1</td><td rowspan="1" colspan="1">7&#x000b7;47</td></tr><tr><td rowspan="1" colspan="1">Plasma cholesterol (mmol/l)</td><td rowspan="1" colspan="1">4&#x000b7;29</td><td rowspan="1" colspan="1">0&#x000b7;91</td></tr><tr><td rowspan="1" colspan="1">Plasma glucose (mmol/l)</td><td rowspan="1" colspan="1">7&#x000b7;16</td><td rowspan="1" colspan="1">1&#x000b7;41</td></tr><tr><td rowspan="1" colspan="1">Plasma HDL-cholesterol (mmol/l)</td><td rowspan="1" colspan="1">1&#x000b7;18</td><td rowspan="1" colspan="1">0&#x000b7;39</td></tr><tr><td rowspan="1" colspan="1">Plasma LDL-cholesterol (mmol/l)</td><td rowspan="1" colspan="1">2&#x000b7;59</td><td rowspan="1" colspan="1">0&#x000b7;87</td></tr><tr><td rowspan="1" colspan="1">TAG (pmol/l)</td><td rowspan="1" colspan="1">1&#x000b7;42</td><td rowspan="1" colspan="1">0&#x000b7;51</td></tr><tr><td rowspan="1" colspan="1">NEFA (mmol/l)</td><td rowspan="1" colspan="1">0&#x000b7;59</td><td rowspan="1" colspan="1">0&#x000b7;14</td></tr><tr><td rowspan="1" colspan="1">Fasting plasma insulin (pg/ml)</td><td rowspan="1" colspan="1">407&#x000b7;70</td><td rowspan="1" colspan="1">208&#x000b7;41</td></tr><tr><td rowspan="1" colspan="1">HOMA-IR</td><td rowspan="1" colspan="1">3&#x000b7;35</td><td rowspan="1" colspan="1">2&#x000b7;19</td></tr><tr><td rowspan="1" colspan="1">HOMA-&#x003b2;</td><td rowspan="1" colspan="1">405</td><td rowspan="1" colspan="1">190</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>HOMA-IR, homeostasis model assessment of insulin resistance; HOMA-&#x003b2;, homeostasis
model assessment of &#x003b2;-cell function.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec1-2"><title>Study design</title><p>In a cross-over design, volunteers (<italic>n</italic> 8) were randomised and
double-blinded into two groups matched for BMI as well as age and given a single capsule
of either 0&#x000b7;47&#x000a0;g of Mirtoselect<sup>&#x000ae;</sup> (a standardised bilberry extract (36 % (w/w)
anthocyanins)) which equates to about 50&#x000a0;g of fresh bilberries formulated in gelatin
capsules or a control capsule consisting of microcrystalline cellulose in an opaque
gelatin capsule, followed by oral glucose tolerance testing (OGTT). The reverse procedure
was conducted following a 2-week washout period. The volunteers were asked to consume a
low-phytochemical diet 3 d before taking the capsule and for the 24&#x000a0;h after taking the
capsule on both occasions. In addition the volunteers were asked to record what they ate
over the same period in a food diary to ensure that they adhered to the low-phytochemical
diet. Subjects were reimbursed travelling expenses on completion of the study.</p></sec><sec id="sec1-3"><title>Oral glucose tolerance testing</title><p>In the evening before the test on each visit the volunteers were asked to consume the
same low-phytochemical meal. Volunteers were fasted (10&#x02013;12&#x000a0;h) overnight before the OGTT.
Venous blood samples were taken through an indwelling cannula inserted into a forearm vein
at &#x02013;15, &#x02013;10 and &#x02013;5 (fasted) and at 15, 30, 45, 60, 90, 120, 150 and 300&#x000a0;min after
consuming 75&#x000a0;g of Polycal liquid (carbohydrate, 61&#x000b7;9 %; polysaccharide, 49&#x000b7;2 %; sugars,
12&#x000b7;2 %; glucose, 0&#x000b7;6 %; maltose, 11&#x000b7;6 %; <uri xlink:type="simple" xlink:href="http://www.nutricia.co.uk">http://www.nutricia.co.uk</uri>). Polycal was selected as the main
carbohydrate as it is in the form of polysaccharides and this is closer to normal dietary
consumption than glucose only. It is often used in hospitals as a standard glucose load
for OGTT as it is more palatable. The volunteers consumed the appropriate capsule (0&#x000a0;min),
glucose load and a further sample of water (70&#x000a0;ml) within 3&#x000a0;min. For those volunteers
taking the control capsule, additional sugar (fructose and dextrose/glucose) was added
double-blinded to the water to match the free sugar content of the Mirtoselect<sup>&#x000ae;</sup>
capsules. Movement during the 300&#x000a0;min OGTT was kept to a minimum. Plasma glucose
concentrations were measured in triplicate using an automated clinical analyser (Kone
Oyj). Plasma insulin was measured in duplicate using an ELISA assay (Mercodia). The inter-
and intra-assay CV were 2&#x000b7;6&#x02013;3&#x000b7;6 and 2&#x000b7;8&#x02013;3&#x000b7;4 %, respectively. Homeostasis model assessment
of insulin resistance (HOMA-IR) was measured using the fasting glucose and insulin
values.</p></sec><sec id="sec1-4"><title>Metabolic profile</title><p>An automated clinical analyser (Kone Oyj) was used for the analysis of plasma glucose,
TAG, LDL, HDL, NEFA and cholesterol using commercial kits (Microgenics GmbH).</p></sec><sec id="sec1-5"><title>Mirtoselect<sup>&#x000ae;</sup></title><p>Mirtoselect<sup>&#x000ae;</sup> is a standardised hydro-alcoholic extract of <italic>Vaccinium
myrtillus</italic> L. berries (Mirtoselect<sup>&#x000ae;</sup>; Indena S.p.A.) containing 36 %
(w/w) of anthocyanins by HPLC. The extract is obtained from frozen ripe fruit of
<italic>V. myrtillus</italic> L. harvested when ripe during July to September.
Predominant anthocyanin constituents are delphinidin-3-galactoside,
delphinidin-3-glucoside, delphinidin-3-arabinoside, cyanidin-3-galactoside and
cyanidin-3-glucoside (Indena datasheet). Other anthocyanins include
cyanidin-3-arabinoside, petunidin-3-galactoside, petunidin-3-glucoside,
petunidin-3-arabinoside, peonidin-3-galactoside, peonidin-3-glucoside,
peonidin-3-arabinoside, malvidin-3-galactoside, malvidin-3-glucoside and
malvidin-3-arabinoside. Mirtoselect<sup>&#x000ae;</sup> also contains other polyphenols (phenolic
acids, flavonols, proanthocyanidins; about 18 %), carbohydrates and aliphatic organic
alcohols (about 29 %), fats (about 0&#x000b7;04 %), N compounds (about 1 %), ash (about 0&#x000b7;7 %),
with the remaining 15 % undefined. The main sugar composition of the
Mirtoselect<sup>&#x000ae;</sup> is fructose, 13 %; glucose, 14 %; and sucrose, 4 % (w/w). No side
effects of the Mirtoselect<sup>&#x000ae;</sup> supplementation were noted. Mirtoselect<sup>&#x000ae;</sup>
batch no. 29993/M2 was used in the present study.</p></sec><sec id="sec1-6"><title>Plasma ELISA</title><p>Plasma was collected in EDTA tubes containing aprotinin with dipeptidyl peptidase-4
(DPP-IV) inhibitor (Millipore Ltd) added at 10 &#x000b5;l/ml and stored at &#x02013;70&#x000b0;C until analysis.
Plasma glucagon, amylin, monocyte chemotactic protein-1 (MCP-1), gastric inhibitory
polypeptide (GIP) and insulin were detected using the commercial Milliplex multiplex ELISA
kit (HMHMAG-34K) according to the manufacturer's instructions (Millipore Ltd). All samples
were run in duplicate. The minimum level of detection of glucagon was 6 pg/ml and the
intra- and inter-assay CV were 3 and 7 %, respectively. The recovery of glucagon added to
plasma was approximately 98 %. Similar values for all the other analytes can be found on
the Millipore website (<uri xlink:type="simple" xlink:href="http://www.millipore.com/">www.millipore.com/</uri>).</p></sec><sec id="sec1-7"><title>Glucagon-like peptide-1 RIA</title><p>Glucagon-like peptide-1 (GLP-1) concentrations in plasma were measured by RIA after
extraction of plasma with 70 % ethanol (v/v, final concentration). Carboxy-terminal GLP-1
immunoreactivity was determined using antiserum 89390 which has an absolute requirement
for the intact amidated carboxy-terminus of GLP-1 7&#x02013;36 amide and cross-reacts less than
0&#x000b7;01 % with carboxy-terminally truncated fragments and 89 % with GLP-1 9&#x02013;36 amide, the
primary metabolite of DPP-IV-mediated degradation. The sum of the two components (total
GLP-1 concentration) reflects the rate of secretion of the L-cell. Sensitivity was below
1&#x000a0;pmol/l, and intra-assay CV below 5 %<sup>(</sup><xref rid="ref25" ref-type="bibr">
<sup>25</sup>
</xref><sup>)</sup>.</p></sec><sec id="sec1-8"><title>Antioxidant assays</title><p>The ferric-reducing activity of plasma (FRAP) assay (Benzie &#x00026;
Strain<sup>(</sup><xref rid="ref26" ref-type="bibr">
<sup>26</sup>
</xref><sup>)</sup>) and the Trolox equivalent antioxidant capacity (TEAC) assay (Dragsted
<italic>et al.</italic><sup>(</sup><xref rid="ref27" ref-type="bibr">
<sup>27</sup>
</xref><sup>)</sup>) were used to define changes to plasma antioxidant capacity. For the
analysis of FRAP in a microplate format, 6 &#x000b5;l of plasma were added with 18 &#x000b5;l of sterile
distilled water and 180 &#x000b5;l of freshly prepared FRAP reagent (250&#x000a0;m<sc>m</sc>-sodium
acetate (pH 3&#x000b7;6), 1&#x000b7;6&#x000a0;m<sc>m</sc>-iron (III) chloride and
0&#x000b7;83&#x000a0;m<sc>m</sc>-2,4,6-Tris(2-pyridyl)-s-triazine). Samples were incubated at 37&#x000b0;C for
4&#x000a0;min and absorbance (A<sub>593nm</sub>; Dynex Technologies) recorded after 4&#x000a0;min and
after a further 30&#x000a0;min at 37&#x000b0;C. The difference in A<sub>593nm</sub> between samples and
blanks was calculated and compared with a standard curve of Fe(II) standard solutions
(50&#x02013;1000 &#x000b5;<sc>m</sc>). For TEAC analysis a proprietary assay (TEAC Assay; Sigma CS0970)
was used and conducted according to the manufacturer's recommendations. Briefly, 10 &#x000b5;l of
plasma were added to 20 &#x000b5;l of myoglobin solution and 150 &#x000b5;l of ABTS
(2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid)) substrate working solution.
Samples were incubated for 5&#x000a0;min at 21&#x000b0;C (as optimised), the reaction stopped and the
A<sub>405nm</sub> recorded (Dynex Technologies). The antioxidant capacity was reported
as Trolox equivalents by referral to the equation obtained from the linear regression of a
Trolox standard curve.</p></sec><sec id="sec1-9"><title>Statistical analysis</title><p>AUC was calculated using the trapezoid approximation. For the incremental version (AUCi),
only the extent of interpolated values above baseline contributed. Values obtained
following the control and extract capsules were compared by paired <italic>t</italic>
tests.</p></sec></sec><sec sec-type="results" id="sec2"><title>Results</title><p>The mean body weight of the volunteers remained stable during the study: 92&#x000b7;3 (<sc>sd</sc>
15&#x000b7;6) kg on visit 1 compared with 92&#x000b7;3 (<sc>sd</sc> 15&#x000b7;4) kg on visit 2. The order in which
the capsules were taken (control <italic>v.</italic> bilberry extract) did not significantly
influence any variable.</p><sec id="sec2-1"><title>Plasma glucose</title><p>The ingestion of the bilberry extract lowered the venous plasma glucose AUCi by 18 %
compared with the placebo (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;003; <xref ref-type="fig" rid="fig01">Fig. 1</xref>). All eight volunteers showed a decrease in plasma glucose AUCi when
taking the bilberry extract compared with the placebo (data not shown). The kinetics of
glycaemia was compared for AUCi for 0&#x02013;60&#x000a0;min and for 60&#x02013;300&#x000a0;min but there was no
difference between the bilberry extract and the placebo (<xref ref-type="fig" rid="fig01">Fig. 1(b)</xref>). However, the incremental plasma glucose concentrations were
significantly lower at 120, 150 and 180&#x000a0;min after taking the bilberry extract compared
with the placebo control (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;04, 0&#x000b7;02 and 0&#x000b7;004, respectively; <xref ref-type="fig" rid="fig01">Fig. 1(a)</xref>). We also examined the effect of the
ingestion of the bilberry extract on the glycaemic profile<sup>(</sup><xref rid="ref28" ref-type="bibr">
<sup>28</sup>
</xref><sup>)</sup>, defined as the duration of the incremental postprandial blood glucose
response divided by the blood glucose incremental peak, but found no effect when compared
with the placebo control (data not shown). <fig id="fig01" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p>(a) Plasma incremental glucose concentrations following consumption of a glucose
load with either a single placebo control (<inline-graphic xlink:href="S2048679013000165_inline1.jpg" mime-subtype="gif"/>) or bilberry
(<italic>Vaccinium myrtillus</italic> L.) extract (<inline-graphic xlink:href="S2048679013000165_inline2.jpg" mime-subtype="gif"/>)
capsule. (b) Incremental AUC (AUCi) from 0 to 300&#x000a0;min, 0 to 60&#x000a0;min and 60 to 300&#x000a0;min
for plasma glucose concentrations under the control (&#x025a0;) and bilberry extract
(<inline-graphic xlink:href="S2048679013000165_inline3.jpg" mime-subtype="gif"/>) conditions. Values are means for eight
subjects, with standard errors represented by vertical bars. Mean value was
significantly different from that for the bilberry extract:
*<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05, **<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;01.</p></caption><graphic xlink:href="S2048679013000165_fig1"/></fig></p></sec><sec id="sec2-2"><title>Plasma insulin</title><p>The ingestion of the bilberry extract lowered the venous plasma insulin AUCi by 18 %
compared with placebo (<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;028; <xref ref-type="fig" rid="fig02">Fig.
2</xref>). All but one volunteer showed a decrease in plasma insulin AUCi when taking the
bilberry extract compared with the control (data not shown). There was a 17 % decrease
(<italic>P</italic>&#x000a0;=&#x000a0;0&#x000b7;04) between the extract and placebo control for the time
60&#x02013;300&#x000a0;min but not for the early postprandial phase (0&#x02013;60&#x000a0;min; <xref ref-type="fig" rid="fig02">Fig. 2(b)</xref>). The incremental plasma insulin concentration was also
lower at 180&#x000a0;min after taking the bilberry extract compared with placebo
(<italic>P</italic>= 0&#x000b7;04; <xref ref-type="fig" rid="fig02">Fig. 2</xref>). <fig id="fig02" orientation="portrait" position="float"><label>Fig. 2.</label><caption><p>(a) Plasma incremental insulin concentrations following consumption of a glucose
load with either a single placebo control (<inline-graphic xlink:href="S2048679013000165_inline1.jpg" mime-subtype="gif"/>) or bilberry
(<italic>Vaccinium myrtillus</italic> L.) extract (<inline-graphic xlink:href="S2048679013000165_inline2.jpg" mime-subtype="gif"/>)
capsule. (b) Incremental AUC (AUCi) from 0 to 300&#x000a0;min, 0 to 60&#x000a0;min and 60 to 300&#x000a0;min
for plasma insulin concentrations under the control (&#x025a0;) and bilberry extract
(<inline-graphic xlink:href="S2048679013000165_inline3.jpg" mime-subtype="gif"/>) conditions. Values are means for eight
subjects, with standard errors represented by vertical bars. * Mean value was
significantly different from that for the bilberry extract
(<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0&#x000b7;05).</p></caption><graphic xlink:href="S2048679013000165_fig2"/></fig></p></sec><sec id="sec2-3"><title>Incretin response</title><p>The impact of the bilberry extract and the placebo ingestion on the gut incretin
hormones, plasma GIP and GLP-1, secreted from the intestinal mucosa, as well as glucagon
and amylin secreted from the pancreas was compared at all time points. There was no
difference in treatment for the AUCi for any of these hormones or for any of the
individual time points compared with placebo (<xref ref-type="fig" rid="fig03">Fig.
3</xref>). <fig id="fig03" orientation="portrait" position="float"><label>Fig. 3.</label><caption><p>Plasma incremental concentrations of (a) gastric inhibitory polypeptide (GIP), (b)
glucagon-like peptide-1 (GLP-1), (c) glucagon and (d) amylin from 0 to 300&#x000a0;min
following consumption of a glucose load with either a single placebo control
(<inline-graphic xlink:href="S2048679013000165_inline1.jpg" mime-subtype="gif"/>) or bilberry (<italic>Vaccinium
myrtillus</italic> L.) extract (<inline-graphic xlink:href="S2048679013000165_inline2.jpg" mime-subtype="gif"/>) capsule. Values are
means for eight subjects, with standard errors represented by vertical bars.</p></caption><graphic xlink:href="S2048679013000165_fig3"/></fig></p></sec><sec id="sec2-4"><title>Inflammatory and oxidative response</title><p>The bilberry extract had no effect on the plasma concentrations of the inflammatory
adipokine MCP-1 (<xref ref-type="fig" rid="fig04">Fig. 4(a)</xref>) compared with the
placebo control at any of the time points studied. Similarly there was no effect of the
bilberry extract on the oxidative state measured by plasma FRAP (<xref ref-type="fig" rid="fig04">Fig. 4(b)</xref>) and TEAC (<xref ref-type="fig" rid="fig04">Fig.
4(c)</xref>), compared with placebo. <fig id="fig04" orientation="portrait" position="float"><label>Fig. 4.</label><caption><p>Plasma concentrations for (a) monocyte chemotactic protein-1 (MCP-1), (b)
ferric-reducing ability of plasma (FRAP) and (c) Trolox equivalent antioxidant
capacity (TEAC) from 0 to 300&#x000a0;min following consumption of a glucose load with
either a single placebo control (<inline-graphic xlink:href="S2048679013000165_inline1.jpg" mime-subtype="gif"/>) or bilberry
(<italic>Vaccinium myrtillus</italic> L.) extract (<inline-graphic xlink:href="S2048679013000165_inline2.jpg" mime-subtype="gif"/>)
capsule. Values are means for eight subjects, with standard errors represented by
vertical bars.</p></caption><graphic xlink:href="S2048679013000165_fig4"/></fig></p></sec></sec><sec sec-type="discussion" id="sec3"><title>Discussion</title><p>The present study shows that the ingestion of a capsule containing concentrated bilberry
extract gives a reduced postprandial glycaemic response in volunteers with T2D controlled by
diet and lifestyle alone compared with an inert placebo capsule. Given that the glucose
concentrations between the volunteers taking the bilberry and control extract are different
during the later time points (120, 150 and 180&#x000a0;min) it might be suggested that the active
ingredient takes some time before it has an effect, perhaps due to digestion or where it is
having its effect, for example, time to reach the gastrointestinal tract. This differs from
previous studies in normal/healthy volunteers where the decrease in the plasma glucose
between the volunteers taking the berries and control extract occurs at the earlier time
points<sup>(</sup><xref rid="ref23" ref-type="bibr">
<sup>23</sup>
</xref><sup>,</sup><xref rid="ref29" ref-type="bibr">
<sup>29</sup>
</xref><sup>,</sup><xref rid="ref30" ref-type="bibr">
<sup>30</sup>
</xref><sup>)</sup>. This may be due to differences in glucose metabolism in volunteers with
T2D or differences between the studies, for example, the ingestion of a capsule may take
longer to reach the gastrointestinal tract compared with a berry pur&#x000e9;e. The bilberry extract
also decreased plasma insulin compared with the control in a profile that mirrors the
postprandial glycaemic response. One explanation is that the decreased plasma insulin is a
result of the lower plasma glucose or the volunteers become more insulin sensitive.</p><p>One study in normal/healthy volunteers that reported a mean decrease in plasma glucose
after 15 and 30&#x000a0;min following the consumption of a commercial apple juice also observed
parallel changes in the plasma concentrations of the incretins, GLP-1 and
GIP<sup>(</sup><xref rid="ref29" ref-type="bibr">
<sup>29</sup>
</xref><sup>)</sup>. Both these incretins are produced in the intestinal mucosa and are
normally secreted when food is eaten in order to reduce glycaemic excursion by causing an
increase in insulin secretion. However, GLP-1 also has other effects such as inhibiting
glucagon secretion from the pancreas and by decreasing the time it takes for food to empty
from the stomach. In the present study we did not find an effect of the bilberry extract on
GIP, GLP-1 or glucagon. Further, we also looked at the effect of the bilberry extract on the
pancreatic hormone amylin which also affects plasma glucose concentration independent of
insulin secretion. Again, we did not observe any effects of the bilberry extract on plasma
amylin compared with the placebo.</p><p>Bilberries are rich in anthocyanins, recognised for their ability to provide and activate
cellular antioxidant protection, inhibit inflammatory gene expression, and consequently
protect against oxidant-induced and inflammatory cell damage and
cytotoxicity<sup>(</sup><xref rid="ref2" ref-type="bibr">
<sup>2</sup>
</xref><sup>&#x02013;</sup><xref rid="ref4" ref-type="bibr">
<sup>4</sup>
</xref><sup>)</sup>. In light of this we investigated the effects of a bilberry extract on
the inflammatory marker MCP-1 that plays a role in the recruitment of monocytes due to the
low-grade inflammation associated with obesity<sup>(</sup><xref rid="ref31" ref-type="bibr">
<sup>31</sup>
</xref><sup>)</sup>. However, in the present study we did not see any changes in plasma
levels of MCP-1 due to the ingestion of the bilberry extract compared with the control.
Similarly, we could not detect any alterations in plasma TEAC or FRAP, both markers of
oxidation. It may well be that any effects of the bilberry extract on markers of
inflammation and oxidation take longer than 5&#x000a0;h to occur. In addition, our sample size of
eight volunteers was modest, and meant that we had 80 % power to detect treatment effects
about 1.5 times the natural within-individual variability (<sc>sd</sc>) in outcome
measurements. Therefore any negative results reported need to be viewed in this context.</p><p>It has been suggested that berry polyphenols inhibit &#x003b1;-glycosidase, the enzyme responsible
for the digestion of sucrose to glucose in the intestinal epithelium. Two anthocyanins
(cyanidin-3-rutinoside<sup>(</sup><xref rid="ref32" ref-type="bibr">
<sup>32</sup>
</xref><sup>)</sup> and cyanidin-3-galactoside<sup>(</sup><xref rid="ref33" ref-type="bibr">
<sup>33</sup>
</xref><sup>,</sup><xref rid="ref34" ref-type="bibr">
<sup>34</sup>
</xref><sup>)</sup>) have been shown <italic>in vitro</italic> to be inhibitors of
&#x003b1;-glucosidase. Cyanidin-3-galactoside is present in bilberries<sup>(</sup><xref rid="ref35" ref-type="bibr">
<sup>35</sup>
</xref><sup>)</sup> and cranberries<sup>(</sup><xref rid="ref24" ref-type="bibr">
<sup>24</sup>
</xref><sup>)</sup>, and has shown a synergistic effect with acarbose<sup>(</sup><xref rid="ref34" ref-type="bibr">
<sup>34</sup>
</xref><sup>)</sup>. Acarbose is used as an inhibitor of &#x003b1;-glucosidase in the treatment of
diabetes. Also proanthocyanidins have shown potent &#x003b1;-glucosidase inhibitory
activity<sup>(</sup><xref rid="ref36" ref-type="bibr">
<sup>36</sup>
</xref><sup>,</sup><xref rid="ref37" ref-type="bibr">
<sup>37</sup>
</xref><sup>)</sup>. The anthocyanins in the bilberry extract are well
documented<sup>(</sup>38,39<sup>)</sup> and include both cyanidin-3-galactoside and
proanthocyanidins. As the glucose load Polycal used here for the OGTT is composed of complex
carbohydrates, the reduced postprandial glycaemia in response to the ingestion of the
bilberry extract may be due in part to a reduction in the breakdown of carbohydrates.</p><p>In addition there is evidence that polyphenols can affect the absorption of glucose across
the intestine. This is thought to be mediated by active Na-dependent transport via Na
glucose co-transporter 1 (SGLT1) and facilitated Na-independent transport via
GLUT2<sup>(</sup><xref rid="ref40" ref-type="bibr">
<sup>40</sup>
</xref><sup>)</sup>. The Na<sup>+</sup>-dependent SGLT1-mediated glucose uptake appears to
be inhibited by several phenolic acids (for example, chlorogenic, ferulic and caffeic
acids)<sup>(</sup><xref rid="ref13" ref-type="bibr">
<sup>13</sup>
</xref><sup>)</sup> as well as by glucosides of quercetin<sup>(</sup><xref rid="ref20" ref-type="bibr">
<sup>20</sup>
</xref><sup>)</sup>. The glucose transport by GLUT2 was inhibited by the flavonols quercetin
and myricetin<sup>(</sup><xref rid="ref19" ref-type="bibr">
<sup>19</sup>
</xref><sup>,</sup><xref rid="ref21" ref-type="bibr">
<sup>21</sup>
</xref><sup>)</sup>. These phenolic acids and flavonols with inhibitory activity against
intestinal glucose uptake are common polyphenolic constituents of berries<sup>(</sup><xref rid="ref41" ref-type="bibr">
<sup>41</sup>
</xref><sup>&#x02013;</sup><xref rid="ref43" ref-type="bibr">
<sup>43</sup>
</xref><sup>)</sup>. Thus, both a reduced breakdown of carbohydrates and lowered intestinal
absorption may contribute to the improved glycaemic excursion. Further studies are needed to
determine which of these mechanisms are more important <italic>in vivo</italic>. For
example, comparison of the bilberry extract responses to Polycal <italic>v.</italic> a
glucose OGTT would resolve how important to the breakdown of carbohydrates is in the action
of the bilberry extract. Although dietary fibre has been shown to affect postprandial
glucose<sup>(</sup><xref rid="ref44" ref-type="bibr">
<sup>44</sup>
</xref><sup>)</sup>, the bilberry extract used only contains 18&#x000a0;mg of dietary fibre (15&#x000a0;mg
in soluble form). This small quantity is unlikely to explain the reduced glycaemic response.
Future studies would also focus on dose&#x02013;response effects to support the observed changes in
postprandial glucose in volunteers with and without T2D.</p><p>In addition to berries, other foods rich in polyphenols have been implicated in modifying
glycaemic response. Various studies on the effect of coffee have suggested that the
chlorogenic acid in coffee might have an antagonistic effect on the transport of
sucrose<sup>(</sup><xref rid="ref45" ref-type="bibr">
<sup>45</sup>
</xref><sup>)</sup> and attenuate the glycaemic response to sucrose<sup>(</sup><xref rid="ref46" ref-type="bibr">
<sup>46</sup>
</xref><sup>)</sup>. However, as far as we know, none of these studies has shown a change in
the AUCi values for glucose or insulin in response to the polyphenols compared with the
control.</p><p>In conclusion, to our knowledge this is the first report showing that ingestion of a
concentrated bilberry extract at amounts that can be easily tolerated produces a reduced
AUCi postprandial glycaemia and insulinaemia in volunteers with T2D. The probable
mechanism(s) for the reduced glycaemic response are reduced rates of carbohydrate digestion
and/or absorption. The use of berry polyphenols as phytochemicals capable of lowering the
glycaemia response to carbohydrates not only in subjects with diabetes but also in those
with impaired glucose tolerance control may prove to be useful in helping control blood
sugar. Such a strategy could complement the effectiveness of other lifestyle interventions
such as avoidance of overweight and the need to take regular exercise.</p></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We are grateful to the Scottish Government Rural and Environment Science and Analytical
Services (RESAS) for funding. We thank staff in The Human Nutrition Unit at the University
of Aberdeen, Rowett Institute of Nutrition and Health for their assistance with the study,
and Indena S.p.A. for supplying the Mirtoselect<sup>&#x000ae;</sup> bilberry extract.</p><p>N. H. contributed to the study design, data collection and analysis. M. C. and K.-M. M.
contributed to the study design and data collection. J. J. H. and C. B. contributed to the
data collection. G. H. contributed to the statistical analysis of the data. N. H, C. B., J.
J. H., W. R. and G. H. all contributed to the writing of the manuscript.</p><p>None of the authors had any conflicts of interest.</p></ack><ref-list><title>References</title><ref id="ref1"><label>1.</label><mixed-citation publication-type="journal"><name><surname>Ceriello</surname><given-names>A</given-names></name> &#x00026; <name><surname>Testa</surname><given-names>R</given-names></name> (<year>2009</year>) <article-title>Antioxidant anti-inflammatory treatment in type
2 diabetes</article-title>. <source>Diabetes Care</source><volume>32</volume>, <issue>Suppl. 2</issue>,
<fpage>S232</fpage>&#x02013;<lpage>S236</lpage><pub-id pub-id-type="pmid">19875557</pub-id></mixed-citation></ref><ref id="ref2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>Zafra-Stone</surname><given-names>S</given-names></name>, <name><surname>Yasmin</surname><given-names>T</given-names></name>, <name><surname>Bagchi</surname><given-names>M</given-names></name>, <etal/> (<year>2007</year>) <article-title>Berry anthocyanins as novel
antioxidants in human health and disease prevention</article-title>. <source>Mol Nutr
Food Res</source><volume>51</volume>, <fpage>675</fpage>&#x02013;<lpage>683</lpage><pub-id pub-id-type="pmid">17533652</pub-id></mixed-citation></ref><ref id="ref3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Tsuda</surname><given-names>T</given-names></name> (<year>2008</year>) <article-title>Regulation of adipocyte function by
anthocyanins; possibility of preventing the metabolic syndrome</article-title>.
<source>J Agric Food Chem</source><volume>56</volume>, <fpage>642</fpage>&#x02013;<lpage>646</lpage><pub-id pub-id-type="pmid">18211021</pub-id></mixed-citation></ref><ref id="ref4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Neto</surname><given-names>CC</given-names></name> (<year>2007</year>) <article-title>Cranberry and blueberry: evidence for
protective effects against cancer and vascular diseases</article-title>. <source>Mol
Nutr Food Res</source><volume>51</volume>, <fpage>652</fpage>&#x02013;<lpage>664</lpage><pub-id pub-id-type="pmid">17533651</pub-id></mixed-citation></ref><ref id="ref5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Basu</surname><given-names>A</given-names></name>, <name><surname>Du</surname><given-names>M</given-names></name>, <name><surname>Leyva</surname><given-names>MJ</given-names></name>, <etal/> (<year>2010</year>) <article-title>Blueberries decrease cardiovascular
risk factors in obese men and women with metabolic syndrome</article-title>. <source>J
Nutr</source><volume>140</volume>, <fpage>1582</fpage>&#x02013;<lpage>1587</lpage><pub-id pub-id-type="pmid">20660279</pub-id></mixed-citation></ref><ref id="ref6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Stull</surname><given-names>AJ</given-names></name>, <name><surname>Cash</surname><given-names>KC</given-names></name>, <name><surname>Johnson</surname><given-names>WD</given-names></name>, <etal/> (<year>2010</year>) <article-title>Bioactives in blueberries improve
insulin sensitivity in obese, insulin-resistant men and women</article-title>. <source>J
Nutr</source><volume>140</volume>, <fpage>1764</fpage>&#x02013;<lpage>1768</lpage><pub-id pub-id-type="pmid">20724487</pub-id></mixed-citation></ref><ref id="ref7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Karlsen</surname><given-names>A</given-names></name>, <name><surname>Paur</surname><given-names>I</given-names></name>, <name><surname>B&#x000f8;hn</surname><given-names>SK</given-names></name>, <etal/> (<year>2010</year>) <article-title>Bilberry juice modulates plasma
concentration of NF-&#x003ba;B related inflammatory markers in subjects at increased risk of
CVD</article-title>. <source>Eur J Nutr</source><volume>49</volume>, <fpage>345</fpage>&#x02013;<lpage>355</lpage><pub-id pub-id-type="pmid">20119859</pub-id></mixed-citation></ref><ref id="ref8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Prior</surname><given-names>RL</given-names></name>, <name><surname>Wilkes</surname><given-names>SE</given-names></name>, <name><surname>Rogers</surname><given-names>TR</given-names></name>, <etal/> (<year>2010</year>) <article-title>Purified blueberry anthocyanins and
blueberry juice alter development of obesity in mice fed an obesogenic high-fat
diet</article-title>. <source>J Agric Food Chem</source><volume>58</volume>, <fpage>3970</fpage>&#x02013;<lpage>3976</lpage><pub-id pub-id-type="pmid">20148514</pub-id></mixed-citation></ref><ref id="ref9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>DeFuria</surname><given-names>J</given-names></name>, <name><surname>Bennett</surname><given-names>G</given-names></name>, <name><surname>Strissel</surname><given-names>KJ</given-names></name>, <etal/> (<year>2009</year>) <article-title>Dietary blueberry attenuates
whole-body insulin resistance in high fat-fed mice by reducing adipocyte death and its
inflammatory sequelae</article-title>. <source>J Nutr</source><volume>139</volume>, <fpage>1510</fpage>&#x02013;<lpage>1516</lpage><pub-id pub-id-type="pmid">19515743</pub-id></mixed-citation></ref><ref id="ref10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Prior</surname><given-names>RL</given-names></name>, <name><surname>Wu</surname><given-names>X</given-names></name>, <name><surname>Gu</surname><given-names>L</given-names></name>, <etal/> (<year>2008</year>) <article-title>Whole berries <italic>versus</italic>
berry anthocyanins: interactions with dietary fat levels in the C57BL/6J mouse model of
obesity</article-title>. <source>J Agric Food Chem</source><volume>56</volume>, <fpage>647</fpage>&#x02013;<lpage>653</lpage><pub-id pub-id-type="pmid">18211017</pub-id></mixed-citation></ref><ref id="ref11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Guo</surname><given-names>H</given-names></name>, <name><surname>Li</surname><given-names>D</given-names></name>, <name><surname>Ling</surname><given-names>W</given-names></name>, <etal/> (<year>2011</year>) <article-title>Anthocyanin inhibits high
glucose-induced hepatic mtGPAT1 activation and prevents fatty acid synthesis through
PKC&#x003b6;</article-title>. <source>J Lipid Res</source><volume>52</volume>, <fpage>908</fpage>&#x02013;<lpage>922</lpage><pub-id pub-id-type="pmid">21343633</pub-id></mixed-citation></ref><ref id="ref12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Jayaprakasam</surname><given-names>B</given-names></name>, <name><surname>Olson</surname><given-names>LK</given-names></name>, <name><surname>Schutzki</surname><given-names>RE</given-names></name>, <etal/> (<year>2006</year>) <article-title>Amelioration of obesity and glucose
intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in Cornelian
cherry (<italic>Cornus mas</italic>)</article-title>. <source>J Agric Food Chem</source><volume>54</volume>, <fpage>243</fpage>&#x02013;<lpage>248</lpage><pub-id pub-id-type="pmid">16390206</pub-id></mixed-citation></ref><ref id="ref13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Welsch</surname><given-names>CA</given-names></name>, <name><surname>Lachance</surname><given-names>PA</given-names></name> &#x00026; <name><surname>Wasserman</surname><given-names>BP</given-names></name> (<year>1989</year>) <article-title>Dietary phenolic compounds: inhibition of
Na<sup>+</sup>-dependent <sc>d</sc>-glucose uptake in rat intestinal brush border
membrane vesicles</article-title>. <source>J Nutr</source><volume>119</volume>, <fpage>1698</fpage>&#x02013;<lpage>1704</lpage><pub-id pub-id-type="pmid">2600675</pub-id></mixed-citation></ref><ref id="ref14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Matsui</surname><given-names>T</given-names></name>, <name><surname>Tanaka</surname><given-names>T</given-names></name>, <name><surname>Tamura</surname><given-names>S</given-names></name>, <etal/> (<year>2007</year>) <article-title>&#x003b1;-Glucosidase inhibitory profile of
catechins and theaflavins</article-title>. <source>J Agric Food Chem</source><volume>55</volume>, <fpage>99</fpage>&#x02013;<lpage>105</lpage><pub-id pub-id-type="pmid">17199319</pub-id></mixed-citation></ref><ref id="ref15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Hanamura</surname><given-names>T</given-names></name> (<year>2006</year>) <article-title>Antihyperglycemic effect of polyphenols from
acerola (<italic>Malpighia emarginata</italic> DC.) fruit</article-title>.
<source>Biosci Biotechnol Biochem</source><volume>70</volume>, <fpage>1813</fpage>&#x02013;<lpage>1820</lpage><pub-id pub-id-type="pmid">16926491</pub-id></mixed-citation></ref><ref id="ref16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Hanamura</surname><given-names>T</given-names></name>, <name><surname>Hagiwara</surname><given-names>T</given-names></name> &#x00026; <name><surname>Kawagishi</surname><given-names>H</given-names></name> (<year>2005</year>) <article-title>Structural and functional characterization of
polyphenols isolated from acerola (<italic>Malpighia emarginata</italic> DC.)
fruit</article-title>. <source>Biosci Biotechnol Biochem</source><volume>69</volume>, <fpage>280</fpage>&#x02013;<lpage>286</lpage><pub-id pub-id-type="pmid">15725651</pub-id></mixed-citation></ref><ref id="ref17"><label>17.</label><mixed-citation publication-type="journal"><name><surname>Iwai</surname><given-names>K</given-names></name>, <name><surname>Kim</surname><given-names>M</given-names></name>, <name><surname>Onodera</surname><given-names>A</given-names></name>, <etal/> (<year>2006</year>) <article-title>&#x003b1;-Glucosidase inhibitory and
antihyperglycemic effects of polyphenols in the fruit of <italic>Viburnum
dilatatum</italic> Thunb</article-title>. <source>J Agric Food Chem</source><volume>54</volume>, <fpage>4588</fpage>&#x02013;<lpage>4592</lpage><pub-id pub-id-type="pmid">16787002</pub-id></mixed-citation></ref><ref id="ref18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Kobayashi</surname><given-names>Y</given-names></name>, <name><surname>Suzuki</surname><given-names>M</given-names></name>, <name><surname>Satsu</surname><given-names>H</given-names></name>, <etal/> (<year>2000</year>) <article-title>Green tea polyphenols inhibit the
sodium-dependent glucose transporter of intestinal epithelial cells by a competitive
mechanism</article-title>. <source>J Agric Food Chem</source><volume>48</volume>, <fpage>5618</fpage>&#x02013;<lpage>5623</lpage><pub-id pub-id-type="pmid">11087528</pub-id></mixed-citation></ref><ref id="ref19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Song</surname><given-names>J</given-names></name>, <name><surname>Kwon</surname><given-names>O</given-names></name>, <name><surname>Chen</surname><given-names>S</given-names></name>, <etal/> (<year>2002</year>) <article-title>Flavonoid inhibition of
sodium-dependent vitamin C transporter 1 (SVCT1) and glucose transporter isoform 2
(GLUT2), intestinal transporters for vitamin C and glucose</article-title>. <source>J
Biol Chem</source><volume>277</volume>, <fpage>15252</fpage>&#x02013;<lpage>15260</lpage><pub-id pub-id-type="pmid">11834736</pub-id></mixed-citation></ref><ref id="ref20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Cermak</surname><given-names>R</given-names></name>, <name><surname>Landgraf</surname><given-names>S</given-names></name> &#x00026; <name><surname>Wolffram</surname><given-names>S</given-names></name> (<year>2004</year>) <article-title>Quercetin glucosides inhibit glucose uptake
into brush-border-membrane vesicles of porcine jejunum</article-title>. <source>Br J
Nutr</source><volume>91</volume>, <fpage>849</fpage>&#x02013;<lpage>855</lpage><pub-id pub-id-type="pmid">15182388</pub-id></mixed-citation></ref><ref id="ref21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Johnston</surname><given-names>K</given-names></name>, <name><surname>Sharp</surname><given-names>P</given-names></name>, <name><surname>Clifford</surname><given-names>M</given-names></name>, <etal/> (<year>2005</year>) <article-title>Dietary polyphenols decrease glucose
uptake by human intestinal Caco-2 cells</article-title>. <source>FEBS Lett</source><volume>579</volume>, <fpage>1653</fpage>&#x02013;<lpage>1657</lpage><pub-id pub-id-type="pmid">15757656</pub-id></mixed-citation></ref><ref id="ref22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Matsui</surname><given-names>T</given-names></name>, <name><surname>Ebuchi</surname><given-names>S</given-names></name>, <name><surname>Kobayashi</surname><given-names>M</given-names></name>, <etal/> (<year>2002</year>) <article-title>Anti-hyperglycemic effect of
diacylated anthocyanin derived from <italic>Ipomoea batatas</italic> cultivar
Ayamurasaki can be achieved through the &#x003b1;-glucosidase inhibitory action</article-title>.
<source>J Agric Food Chem</source><volume>50</volume>, <fpage>7244</fpage>&#x02013;<lpage>7248</lpage><pub-id pub-id-type="pmid">12452639</pub-id></mixed-citation></ref><ref id="ref23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>T&#x000f6;rr&#x000f6;nen</surname><given-names>R</given-names></name>, <name><surname>Sarkkinen</surname><given-names>E</given-names></name>, <name><surname>Tapola</surname><given-names>N</given-names></name>, <etal/> (<year>2010</year>) <article-title>Berries modify the postprandial plasma
glucose response to sucrose in healthy subjects</article-title>. <source>Br J Nutr</source><volume>103</volume>, <fpage>1094</fpage>&#x02013;<lpage>1097</lpage><pub-id pub-id-type="pmid">19930765</pub-id></mixed-citation></ref><ref id="ref24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>Wilson</surname><given-names>T</given-names></name>, <name><surname>Singh</surname><given-names>AP</given-names></name>, <name><surname>Vorsa</surname><given-names>N</given-names></name>, <etal/> (<year>2008</year>) <article-title>Human glycemic response and phenolic
content of unsweetened cranberry juice</article-title>. <source>J Med Food</source><volume>11</volume>, <fpage>46</fpage>&#x02013;<lpage>54</lpage><pub-id pub-id-type="pmid">18361737</pub-id></mixed-citation></ref><ref id="ref25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Orskov</surname><given-names>C</given-names></name>, <name><surname>Rabenhoj</surname><given-names>L</given-names></name>, <name><surname>Wettergren</surname><given-names>A</given-names></name>, <etal/> (<year>1994</year>) <article-title>Tissue and plasma concentrations of
amidated and glycine-extended glucagon-like peptide I in humans</article-title>.
<source>Diabetes</source><volume>43</volume>, <fpage>535</fpage>&#x02013;<lpage>539</lpage><pub-id pub-id-type="pmid">8138058</pub-id></mixed-citation></ref><ref id="ref26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Benzie</surname><given-names>IF</given-names></name> &#x00026; <name><surname>Strain</surname><given-names>JJ</given-names></name> (<year>1996</year>) <article-title>The ferric reducing ability of plasma (FRAP) as
a measure of &#x0201c;antioxidant power&#x0201d;: the FRAP assay</article-title>. <source>Anal Biochem</source><volume>239</volume>, <fpage>70</fpage>&#x02013;<lpage>76</lpage><pub-id pub-id-type="pmid">8660627</pub-id></mixed-citation></ref><ref id="ref27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>Dragsted</surname><given-names>LO</given-names></name>, <name><surname>Pedersen</surname><given-names>A</given-names></name>, <name><surname>Hermetter</surname><given-names>A</given-names></name>, <etal/> (<year>2004</year>) <article-title>The 6-a-day study: effects of fruit
and vegetables on markers of oxidative stress and antioxidative defense in healthy
nonsmokers</article-title>. <source>Am J Clin Nutr</source><volume>79</volume>, <fpage>1060</fpage>&#x02013;<lpage>1072</lpage><pub-id pub-id-type="pmid">15159237</pub-id></mixed-citation></ref><ref id="ref28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>T&#x000f6;rr&#x000f6;nen</surname><given-names>R</given-names></name>, <name><surname>Kolehmainen</surname><given-names>M</given-names></name>, <name><surname>Sarkkinen</surname><given-names>E</given-names></name>, <etal/> (<year>2012</year>) <article-title>Postprandial glucose, insulin, and
free fatty acid responses to sucrose consumed with blackcurrants and lingonberries in
healthy women</article-title>. <source>Am J Clin Nutr</source><volume>96</volume>, <fpage>527</fpage>&#x02013;<lpage>533</lpage><pub-id pub-id-type="pmid">22854401</pub-id></mixed-citation></ref><ref id="ref29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Johnston</surname><given-names>KL</given-names></name>, <name><surname>Clifford</surname><given-names>MN</given-names></name> &#x00026; <name><surname>Morgan</surname><given-names>LM</given-names></name> (<year>2002</year>) <article-title>Possible role for apple juice phenolic
compounds in the acute modification of glucose tolerance and gastrointestinal hormone
secretion in humans</article-title>. <source>J Sci Food Agric</source><volume>82</volume>, <fpage>1800</fpage>&#x02013;<lpage>1805</lpage></mixed-citation></ref><ref id="ref30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>T&#x000f6;rr&#x000f6;nen</surname><given-names>R</given-names></name>, <name><surname>Sarkkinen</surname><given-names>E</given-names></name>, <name><surname>Niskanen</surname><given-names>T</given-names></name>, <etal/> (<year>2012</year>) <article-title>Postprandial glucose, insulin and
glucagon-like peptide 1 responses to sucrose ingested with berries in healthy
subjects</article-title>. <source>Br J Nutr</source><volume>107</volume>, <fpage>1445</fpage>&#x02013;<lpage>1451</lpage><pub-id pub-id-type="pmid">21929838</pub-id></mixed-citation></ref><ref id="ref31"><label>31.</label><mixed-citation publication-type="journal"><name><surname>Panee</surname><given-names>J</given-names></name> (<year>2012</year>) <article-title>Monocyte chemoattractant protein 1 (MCP-1) in
obesity and diabetes</article-title>. <source>Cytokine</source><volume>60</volume>, <fpage>1</fpage>&#x02013;<lpage>12</lpage><pub-id pub-id-type="pmid">22766373</pub-id></mixed-citation></ref><ref id="ref32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>Adisakwattana</surname><given-names>S</given-names></name>, <name><surname>Ngamrojanavanich</surname><given-names>N</given-names></name>, <name><surname>Kalampakorn</surname><given-names>K</given-names></name>, <etal/> (<year>2004</year>) <article-title>Inhibitory activity of
cyanidin-3-rutinoside on &#x003b1;-glucosidase</article-title>. <source>J Enzyme Inhib Med Chem</source><volume>19</volume>, <fpage>313</fpage>&#x02013;<lpage>316</lpage><pub-id pub-id-type="pmid">15558946</pub-id></mixed-citation></ref><ref id="ref33"><label>33.</label><mixed-citation publication-type="journal"><name><surname>Akkarachiyasit</surname><given-names>S</given-names></name>, <name><surname>Yibchok-Anun</surname><given-names>S</given-names></name>, <name><surname>Wacharasindhu</surname><given-names>S</given-names></name>, <etal/> (<year>2011</year>) <article-title><italic>In vitro</italic> inhibitory
effects of cyandin-3-rutinoside on pancreatic &#x003b1;-amylase and its combined effect with
acarbose</article-title>. <source>Molecules</source><volume>16</volume>, <fpage>2075</fpage>&#x02013;<lpage>2083</lpage><pub-id pub-id-type="pmid">21368719</pub-id></mixed-citation></ref><ref id="ref34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Adisakwattana</surname><given-names>S</given-names></name>, <name><surname>Charoenlertkul</surname><given-names>P</given-names></name> &#x00026; <name><surname>Yibchok-Anun</surname><given-names>S</given-names></name> (<year>2009</year>) <article-title>&#x003b1;-Glucosidase inhibitory activity of
cyanidin-3-galactoside and synergistic effect with acarbose</article-title>. <source>J
Enzyme Inhib Med Chem</source><volume>24</volume>, <fpage>65</fpage>&#x02013;<lpage>69</lpage><pub-id pub-id-type="pmid">18615280</pub-id></mixed-citation></ref><ref id="ref35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Buchert</surname><given-names>J</given-names></name>, <name><surname>Koponen</surname><given-names>JM</given-names></name>, <name><surname>Suutarinen</surname><given-names>M</given-names></name>, <etal/> (<year>2005</year>) <article-title>Effect of enzyme-aided pressing on
anthocyanin yield and profiles in bilberry and blackcurrant juices</article-title>.
<source>J Sci Food Agric</source><volume>85</volume>, <fpage>2548</fpage>&#x02013;<lpage>2556</lpage></mixed-citation></ref><ref id="ref36"><label>36.</label><mixed-citation publication-type="journal"><name><surname>Sch&#x000e4;fer</surname><given-names>A</given-names></name> &#x00026; <name><surname>H&#x000f6;gger</surname><given-names>P</given-names></name> (<year>2007</year>) <article-title>Oligomeric procyanidins of French maritime pine
bark extract (Pycnogenol<sup>&#x000ae;</sup>) effectively inhibit &#x003b1;-glucosidase</article-title>.
<source>Diabetes Res Clin Pract</source><volume>77</volume>, <fpage>41</fpage>&#x02013;<lpage>46</lpage><pub-id pub-id-type="pmid">17098323</pub-id></mixed-citation></ref><ref id="ref37"><label>37.</label><mixed-citation publication-type="journal"><name><surname>Kumar</surname><given-names>S</given-names></name>, <name><surname>Narwal</surname><given-names>S</given-names></name>, <name><surname>Kumar</surname><given-names>V</given-names></name>, <etal/> (<year>2011</year>) <article-title>&#x003b1;-Glucosidase inhibitors from plants:
a natural approach to treat diabetes</article-title>. <source>Pharmacogn Rev</source><volume>5</volume>, <fpage>19</fpage>&#x02013;<lpage>29</lpage><pub-id pub-id-type="pmid">22096315</pub-id></mixed-citation></ref><ref id="ref38"><label>38.</label><mixed-citation publication-type="journal"><name><surname>Cai</surname><given-names>H</given-names></name>, <name><surname>Thomasset</surname><given-names>SC</given-names></name>, <name><surname>Berry</surname><given-names>DP</given-names></name>, <etal/> (<year>2011</year>) <article-title>Determination of anthocyanins in the
urine of patients with colorectal liver metastases after administration of bilberry
extract</article-title>. <source>Biomed Chromatogr</source><volume>25</volume>, <fpage>660</fpage>&#x02013;<lpage>663</lpage><pub-id pub-id-type="pmid">20812200</pub-id></mixed-citation></ref><ref id="ref39"><label>39.</label><mixed-citation publication-type="journal"><name><surname>Cooke</surname><given-names>DN</given-names></name>, <name><surname>Thomasset</surname><given-names>S</given-names></name>, <name><surname>Boocock</surname><given-names>DJ</given-names></name>, <etal/> (<year>2006</year>) <article-title>Development of analyses by
high-performance liquid chromatography and liquid chromatography/tandem mass
spectrometry of bilberry (<italic>Vaccinium myrtilus</italic>) anthocyanins in human
plasma and urine</article-title>. <source>J Agric Food Chem</source><volume>54</volume>, <fpage>7009</fpage>&#x02013;<lpage>7013</lpage><pub-id pub-id-type="pmid">16968056</pub-id></mixed-citation></ref><ref id="ref40"><label>40.</label><mixed-citation publication-type="journal"><name><surname>Levin</surname><given-names>RJ</given-names></name> (<year>1994</year>) <article-title>Digestion and absorption of carbohydrates &#x02013;
from molecules and membranes to humans</article-title>. <source>Am J Clin Nutr</source><volume>59</volume>, <issue>Suppl. 3</issue>,
<fpage>690S</fpage>&#x02013;<lpage>698S</lpage><pub-id pub-id-type="pmid">8116552</pub-id></mixed-citation></ref><ref id="ref41"><label>41.</label><mixed-citation publication-type="journal"><name><surname>M&#x000e4;&#x000e4;tt&#x000e4;-Riihinen</surname><given-names>KR</given-names></name>, <name><surname>Kamal-Eldin</surname><given-names>A</given-names></name>, <name><surname>Mattila</surname><given-names>PH</given-names></name>, <etal/> (<year>2004</year>) <article-title>Distribution and contents of phenolic
compounds in eighteen Scandinavian berry species</article-title>. <source>J Agric Food
Chem</source><volume>52</volume>, <fpage>4477</fpage>&#x02013;<lpage>4486</lpage><pub-id pub-id-type="pmid">15237955</pub-id></mixed-citation></ref><ref id="ref42"><label>42.</label><mixed-citation publication-type="journal"><name><surname>M&#x000e4;&#x000e4;tt&#x000e4;-Riihinen</surname><given-names>KR</given-names></name>, <name><surname>Kamal-Eldin</surname><given-names>A</given-names></name> &#x00026; <name><surname>T&#x000f6;rr&#x000f6;nen</surname><given-names>AR</given-names></name> (<year>2004</year>) <article-title>Identification and quantification of phenolic
compounds in berries of <italic>Fragaria</italic> and <italic>Rubus</italic> species
(family Rosaceae)</article-title>. <source>J Agric Food Chem</source><volume>52</volume>, <fpage>6178</fpage>&#x02013;<lpage>6187</lpage><pub-id pub-id-type="pmid">15453684</pub-id></mixed-citation></ref><ref id="ref43"><label>43.</label><mixed-citation publication-type="journal"><name><surname>Mattila</surname><given-names>P</given-names></name>, <name><surname>Hellstr&#x000f6;m</surname><given-names>J</given-names></name> &#x00026; <name><surname>T&#x000f6;rr&#x000f6;nen</surname><given-names>R</given-names></name> (<year>2006</year>) <article-title>Phenolic acids in berries, fruits, and
beverages</article-title>. <source>J Agric Food Chem</source><volume>54</volume>, <fpage>7193</fpage>&#x02013;<lpage>7199</lpage><pub-id pub-id-type="pmid">16968082</pub-id></mixed-citation></ref><ref id="ref44"><label>44.</label><mixed-citation publication-type="journal"><name><surname>Wood</surname><given-names>PJ</given-names></name> (<year>2007</year>) <article-title>Cereal &#x003b2;-glucans in diet and
health</article-title>. <source>J Cereal Sci</source><volume>46</volume>, <fpage>230</fpage>&#x02013;<lpage>238</lpage></mixed-citation></ref><ref id="ref45"><label>45.</label><mixed-citation publication-type="journal"><name><surname>Thom</surname><given-names>E</given-names></name> (<year>2007</year>) <article-title>The effect of chlorogenic acid enriched coffee
on glucose absorption in healthy volunteers and its effect on body mass when used
long-term in overweight and obese people</article-title>. <source>J Int Med Res</source><volume>35</volume>, <fpage>900</fpage>&#x02013;<lpage>908</lpage><pub-id pub-id-type="pmid">18035001</pub-id></mixed-citation></ref><ref id="ref46"><label>46.</label><mixed-citation publication-type="journal"><name><surname>Johnston</surname><given-names>KL</given-names></name>, <name><surname>Clifford</surname><given-names>MN</given-names></name> &#x00026; <name><surname>Morgan</surname><given-names>LM</given-names></name> (<year>2003</year>) <article-title>Coffee acutely modifies gastrointestinal
hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid
and caffeine</article-title>. <source>Am J Clin Nutr</source><volume>78</volume>, <fpage>728</fpage>&#x02013;<lpage>733</lpage><pub-id pub-id-type="pmid">14522730</pub-id></mixed-citation></ref></ref-list></back></article>